Journal of Applied Physiology Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 92: 248-256, 2002; doi:10.1152/japplphysiol.00434.2001
8750-7587/02 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arieli, R.
Right arrow Articles by Goldenshluger, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arieli, R.
Right arrow Articles by Goldenshluger, A.
Vol. 92, Issue 1, 248-256, January 2002

Modeling pulmonary and CNS O2 toxicity and estimation of parameters for humans

R. Arieli1, A. Yalov2, and A. Goldenshluger3

1 Israel Naval Medical Institute and 2 Israel Defense Force Medical Corps, Haifa 31080; and 3 Department of Statistics, University of Haifa, Haifa 31905, Israel


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
QUANTITATIVE EXPRESSIONS FOR...
SELECTING THE PARAMETERS FOR...
APPENDIX A
APPENDIX B
REFERENCES

10.1152/japplphysiol.00434.2001.---The power expression for cumulative oxygen toxicity and the exponential recovery were successfully applied to various features of oxygen toxicity. From the basic equation, we derived expressions for a protocol in which PO2 changes with time. The parameters of the power equation were solved by using nonlinear regression for the reduction in vital capacity (Delta VC) in humans:  %Delta VC  = 0.0082 × t2(PO2/101.3)4.57, where t is the time in hours and PO2 is expressed in kPa. The recovery of lung volume is  Delta VCt = Delta VCe × e-(-0.42 + 0.00379PO2)t, where Delta VCt is the value at time t of the recovery, Delta VCe is the value at the end of the hyperoxic exposure, and PO2 is the prerecovery oxygen pressure. Data from different experiments on central nervous system (CNS) oxygen toxicity in humans in the hyperbaric chamber (n = 661) were analyzed along with data from actual closed-circuit oxygen diving (n = 2,039) by using a maximum likelihood method. The parameters of the model were solved for the combined data, yielding the power equation for active diving: K = t2 (PO2/101.3)6.8, where t is in minutes. It is suggested that the risk of CNS oxygen toxicity in diving can be derived from the calculated parameter of the normal distribution: Z = [ln(t- 9.63 +3.38 × ln(PO2/101.3)]/2.02. The recovery time constant for CNS oxygen toxicity was calculated from the value obtained for the rat, taking into account the effect of body mass, and yielded the recovery equation: Kt = Ke × e-0.079t, where Kt and Ke are the values of K at time t of the recovery process and at the end of the hyperbaric oxygen exposure, respectively, and t is in minutes.

hyperbaric oxygen; pulmonary oxygen toxicity; central nervous system oxygen toxicity


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
QUANTITATIVE EXPRESSIONS FOR...
SELECTING THE PARAMETERS FOR...
APPENDIX A
APPENDIX B
REFERENCES

HYPERBARIC OXYGEN (HBO) is encountered in clinical treatment in the hyperbaric chamber and in diving. The risk of oxygen toxicity became a prominent issue with the increased use of hyperbaric treatment and the expansion of diving techniques to include oxygen-enriched gas mixtures. However, there is no satisfactory method of calculating the cumulative risk of oxygen toxicity during a HBO exposure. There have been various attempts to quantify the risk of pulmonary oxygen toxicity (9, 15) and central nervous system (CNS) oxygen toxicity. A recent approach of Harabin et al. (18) was to process, in one equation, developing CNS oxygen toxicity, recovery, and the PO2 threshold (with the assumption being that any specified form of oxygen toxicity will not develop below the specified PO2 threshold). However, the toxic process of HBO could differ widely from the recovery process. The toxic process itself, non-steady-state production of reactive oxygen species (ROS) and increased injury, may differ from the steady-state production and removal of ROS, which is the normal state and in which recovery may occur. Therefore, one should not expect that one equation might be applicable to all conditions: developing toxicity, steady state, and recovery. It is not surprising, therefore, that such analyses fail to solve the threshold PO2, when the parameters of an equation describing both oxygen toxicity and the threshold are solved simultaneously for pulmonary oxygen toxicity (15) and for CNS oxygen toxicity (17). During the past few years, we have developed a quantitative approach to both the toxic process (a power expression) and the exponential recovery (1-3, 6, 7, 22) for the various forms of oxygen toxicity in animals and humans. This approach has been used satisfactorily to interpret various published data and successfully employed to predict the outcome of HBO exposures on CNS oxygen toxicity (6, 7). Because the possibilities of exposing humans to toxic levels of oxygen are limited, our present strategy is to discover the laws of oxygen toxicity in other mammals and to apply them with the appropriate parameters in humans. Some parameters can be derived from human data, and others, by allometric extrapolation, can be derived from other mammals. The main body of data for CNS oxygen toxicity has been derived from the rat, and studying a larger mammal may help refine the parameters selected for humans.

In the present report, we shall introduce the general power equation for any form of oxygen toxicity. We shall continue with a description of its two facets for measurable damage and for all-or-none effects. A description of the exponential recovery will follow. Parameters will be suggested for the reduction in vital capacity (VC), as one example of measurable damage of oxygen toxicity. Parameters will also be suggested for CNS oxygen toxicity, as one example of the all-or-none phenomena. To conclude, we shall propose hyperoxic exposure limits for humans.


    QUANTITATIVE EXPRESSIONS FOR OXYGEN TOXICITY
TOP
ABSTRACT
INTRODUCTION
QUANTITATIVE EXPRESSIONS FOR...
SELECTING THE PARAMETERS FOR...
APPENDIX A
APPENDIX B
REFERENCES

Quantification Principles

We assumed that an oxygen-damaged measurable physiological variable (DMG) may have the same relationship with time t and PO2 as the ROS that caused the damage (2). We formulated equations for the kinetics of the main ROS by assuming a non-steady state where the action of scavengers is negligible. On the basis of these equations and the published data on various forms of oxygen toxicity, we propose our two power equations (2, 3).

PO2 Effect

In a previous study (2), we showed that the kinetics of ROS suggest a polynomial relation between ROS production and PO2. For example, the non-steady-state rate of production of the hydroxyl radical is d[·OH]/dt = k2(k1[X-][H+]PO2)2 t3(k3[Fe2+] + k4 × k1 × t × PO2), where X- represents the electron source for oxygen reduction, each k stands for a rate constant, and brackets denote concentration (2). In this example, the highest power of PO2 is 3. The exact form of the equations should be related to the various chemical reactions that produce the specific damage. Because these are not known for each specific form of oxygen toxicity, we chose to use the term with the highest power, assuming it to be the dominant term and, therefore, suggested that DMG proportional to  PO<UP><SUB>2</SUB><SUP><IT>c</IT></SUP></UP>, where c is the power of the PO2.

Time Effect

At a constant PO2, nonlinear regression of the various forms of measurable damage caused by oxygen toxicity, such as reduced VC, blunted hypoxic ventilatory drive, and impaired nerve conduction, showed a preference for a time-squared relation, which agrees with the rate of hydrogen peroxide production in a non-steady state: d[H2O2]/dt = k[X-]2 t2[H+]2 PO<UP><SUB>2</SUB><SUP>2</SUP></UP> (2). Although H2O2 is not the most potent ROS, if its production is the slower process, that will be the rate-limiting factor for other ROS. Therefore, we suggested that DMG proportional to  t2 (2).

Power Equations

Based on our study of time and PO2 combinations, we suggested a simplified model in which the most effective term is that of the highest power of PO2 (2)
DMG<IT>=a×t</IT><SUP>2</SUP>P<SC>o</SC><SUP><IT>c</IT></SUP><SUB>2</SUB> (1)
where a is a constant related to the units of measured damage, and c is for the said damage. The same kinetic principles may be carried over to the all-or-none phenomenon of oxygen toxicity, such as the appearance of substernal pain, convulsions, and death. For these forms of oxygen toxicity, Eq. 1 was adapted as (3)
K=t<SUP>2</SUP>P<SC>o</SC><SUP><IT>c</IT></SUP><SUB>2</SUB> (2)
where K is the cumulative oxygen toxicity index. A symptom may appear when K reaches a threshold value Kc. Each form of all-or-none oxygen toxicity would have a different c and Kc. These power equations agree with various phenomena of oxygen toxicity (2, 3), and it was proven possible to use the algorithm derived (3) to predict CNS oxygen toxicity in the rat as a result of a complex HBO exposure (6, 7).

Complex Exposures

For a complex exposure profile at toxic levels of oxygen, it can be shown (APPENDIX A, Eqs. A2-A5) that the cumulative oxygen toxicity indexes, either the parametric DMG or the nonparametric K, follow simple algorithms. In a stepwise exposure [a definite number of intervals (n), each having a selected PO2 (POi) and exposure duration (ti)]
DMG<IT>=a </IT><FENCE><LIM><OP>∑</OP><LL><IT>i=</IT>1</LL><UL><IT>n</IT></UL></LIM> [<IT>t<SUB>i</SUB>×</IT>P<SC>o</SC><SUP>(<IT>c/</IT>2)</SUP><SUB>2<IT>i</IT></SUB>]</FENCE><SUP>2</SUP> (3)

K=<FENCE><LIM><OP>∑</OP><LL>i=1</LL><UL>n</UL></LIM> [t<SUB>i</SUB>×P<SC>o</SC><SUP>(<IT>c/</IT>2)</SUP><SUB>2<IT>i</IT></SUB>]</FENCE><SUP>2</SUP> (4)
For an exposure in which there is a continuous change in PO2 with time, the indexes are solved for their integral forms
DMG<IT>=a </IT><FENCE><LIM><OP>∫</OP><LL>0</LL><UL><IT>t</IT><SUB>ox</SUB></UL></LIM> P<SC>o</SC><SUP>(<IT>c/</IT>2)</SUP><SUB>2</SUB> d<IT>t</IT></FENCE><SUP>2</SUP> (5)

K=<FENCE><LIM><OP>∫</OP><LL>0</LL><UL>t<SUB>ox</SUB></UL></LIM> P<SC>o</SC><SUP>(<IT>c/</IT>2)</SUP><SUB>2</SUB>d<IT>t</IT></FENCE><SUP>2</SUP> (6)
where tox is the exposure time at a toxic level of oxygen.

Recovery Equations

The power equation, which was developed by using the non-steady-state production of ROS, is valid in this toxic PO2 range. We speculate that, below the toxic level, there could be a neutral level (mostly undefined) at which toxicity ceases to develop any further but at which there is still no recovery either. Below this speculated neutral PO2 range is the range in which recovery from the toxic effect takes place. When the complex exposure also contains a nontoxic PO2, it is possible to make a recovery calculation.

It has been suggested that recovery from oxygen toxicity in normoxia follows an exponential function for both oxygen toxicity damage and for all-or-none effects (3, 22)
DMG<SUB><IT>t</IT></SUB><IT>=</IT>DMG<SUB>e</SUB><IT>×e</IT><SUP>−<IT>&tgr;t</IT></SUP> (7)
and
K<SUB>t</SUB>=K<SUB>e</SUB><IT>×e</IT><SUP>−<B>&tgr;t</B></SUP> (8)
where DMGt and Kt are the values of the toxicity indexes at time t of the recovery process, DMGe and Ke are the values at the end of the hyperoxic exposure, and tau  is the recovery time constant. Different manifestations of oxygen toxicity will each have an appropriate time constant. This approach could well describe the recovery of the hypoxic ventilatory drive in rats and the recovery of human VC (22, 13), and, together with the power equation, it has been used successfully to predict recovery from CNS oxygen toxicity in rats when intermittent exposure is used (6).


    SELECTING THE PARAMETERS FOR HUMANS
TOP
ABSTRACT
INTRODUCTION
QUANTITATIVE EXPRESSIONS FOR...
SELECTING THE PARAMETERS FOR...
APPENDIX A
APPENDIX B
REFERENCES

Because the basic processes of toxicity and recovery are common to all mammals, the power equation and the recovery function can be applied to humans with the appropriate parameters, a, c, Kc, and tau , and the variability within each parameter. Two limits of oxygen toxicity are set for human exposure: one related to pulmonary oxygen toxicity and expressed by the reduction in VC, and the other for CNS oxygen toxicity.

Pulmonary Values

There are enough data to derive the parameters for pulmonary oxygen toxicity in the equation DMG = a × t2(PO2/101.3)c. From the data of Clark et al. (11, 12) and Eckenhoff et al. (13), the solved parameters using nonlinear regression are a = 0.0082 and c = 4.57, where DMG = %Delta VC (where Delta VC is the reduction in VC), time t is expressed in hours, and PO2 in kPa. The mean data from those studies, together with the lines solved by the power equation, are shown in Fig. 1. From the data of Eckenhoff et al. (13) and Clark et al. (12), tau  was 0.0128, 0.1047, 0.3740, and 0.5437 h-1 for PO2 values of 106, 152, 203, and 253 kPa, respectively. Recovery of VC, together with the lines representing the exponential solution, is shown in Fig. 2. When the values obtained for tau  were plotted as a function of the PO2 in the preceding hyperoxic exposure, a linear relationship was obtained, such that tau  = -0.420 + 0.00379 PO2 (Fig. 3). Therefore, the recovery of VC will take the form Delta VC in absolute terms: Delta VCt = Delta VCe × e-(-0.42 + 0.00379 PO2)t. As with DMGe in Eq. 7, Delta VCe is the reduction in VC at the end of the hyperoxic exposure.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 1.   Reduction of vital capacity (Delta VC) in humans as a function of time (t) and PO2. Data were taken from Clark et al. (11, 12) and Eckenhoff et al. (13). The lines represent the solution of the power equation.



View larger version (21K):
[in this window]
[in a new window]
 
Fig. 2.   Recovery of human VC as a function of recovery time and the previous PO2 exposure. Data were taken from Clark et al. (12) and Eckenhoff et al. (13). Recovery took place at a PO2 of 21 kPa, except for the 106-kPa exposure in Eckenhoff et al., when the first 33 h of the recovery process were at 50 kPa. Lines represent the solution of the exponential recovery. Inset: recovery after exposure to the three high PO2 values is shown.



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   Time constant (tau ) for the recovery of human VC, calculated from the data presented in Fig. 2, as a function of prerecovery PO2 exposure. The line represents the linear regression solution.

In developing our approach to recovery, we assumed that recovery depends on the level of injury, regardless of the time and PO2 that caused this injury. This will be true if identical injury levels have the same rate of recovery, irrespective of how they were produced. It is not surprising, however, that the rate of recovery depends on the PO2 that caused the loss of VC. For the same decrement in VC, other symptoms differed. Severity of pulmonary symptoms (chest pain, cough, chest tightness, and dyspnea) was greater during exposure to 152 and 203 kPa than to 253 and 304 kPa, neutrophil count was greater after 152 kPa than after the 203-kPa exposure, and postexposure arterial PO2 during exercise dropped after exposure to 152 kPa but not after exposure to 203 or 253 kPa (12). Thus, for the same decrement in VC, the deleterious effects on the lung are related to the pressure at which the insult occurred.

The US Navy recommended oxygen exposure limits that would result in a 2% change in VC and a maximum exposure expected to produce a 10% decrement (20). Thus inserting Delta VC = 2% or Delta VC = 10% into the power equation will set the PO2 and time limits, and the value of t2(PO2/101.3)4.57 at a constant pressure or the cumulative value in a complex exposure should not exceed the values 244 and 1,220, respectively.

CNS Oxygen Toxicity Values

Background. power equation and recovery. For CNS oxygen toxicity, the data for convulsions in humans are not sufficient for derivation of the parameters, and the parameters for other models were derived from symptoms other than convulsions (17). We used our data from rats carefully acclimated to the hyperbaric chamber in air, with the maintenance of thermoneutral conditions and a lack of CO2, to derive the parameters c = 5.61 (SE = 0.35) and Kc = 5.36 × 106 (SE = 3.18 × 106) (n = 290, PO2 range 456-810 kPa, data collected between 1994 and 1999). The mean data and the line representing the prediction of the model are shown in Fig. 4. For the rat, the mean tau  = 0.31 min-1, and thus 95% recovery is achieved within 10 min (6).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 4.   Latency to central nervous system (CNS) oxygen toxicity in the rat as a function of PO2. Mean () and 2 SD (bars) are shown, together with the no. of measurements. The line represents the power equation.

MODULATORS OF CNS OXYGEN TOXICITY. The two principal modulators affecting CNS oxygen toxicity are metabolic rate and CO2 load (4, 5). The quantification of these effects was recently studied by us in the rat. We believe that this form of response is common to various mammals with the appropriate parameters. If the power c does not change with alterations in metabolic rate or CO2, these will be reflected in Kc.

For the metabolic rate effect, CNS oxygen toxicity will develop faster during exercise or when metabolic rate is elevated. This metabolic rate-induced increase in the risk of CNS oxygen toxicity probably involves other known factors, such as cold exposure and high levels of thyroxine (4). We postulated that, at a constant PO2, the latency to CNS oxygen toxicity decreases linearly as CO2 production [or oxygen consumption (VO2)] increases (4) (Fig. 5, right). It is possible to derive Kc at rest (Kc0) and at an increased metabolic rate (Kcex). From our experiment, the latency to CNS oxygen toxicity t = A - B VO2. Inserting this relationship into the power equation yields (Kcex) = t2 PO<UP><SUB>2</SUB><SUP><IT>c</IT></SUP></UP> = (A - B VO2)2 PO<UP><SUB>2</SUB><SUP><IT>c</IT></SUP></UP>. Therefore the ratio
K<SUB>c<SUB>ex</SUB></SUB><IT>/K</IT><SUB><IT>c</IT><SUB>0</SUB></SUB><IT>=</IT>[(<IT>A−B</IT><A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 ex</SUB>)<IT>/</IT>(<IT>A−B</IT><A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2 0</SUB>)]<SUP>2</SUP> (9)
where VO2 ex and VO2 0 are VO2 at increased metabolic rate and at rest, respectively. As metabolic rate increases, Kc decreases, which means that the symptoms will appear at a lower combination of time and oxygen pressure. We have shown that both A and B are a function of PO2 (4)
A=e<SUP>A<SUB>1</SUB>−B<SUB>1</SUB>×P<SC>o</SC><SUB>2</SUB></SUP> (10)
and
B=e<SUP>A<SUB>2</SUB>−B<SUB>2</SUB>×P<SC>o</SC><SUB>2</SUB></SUP> (11)
Therefore, both parameters A and B decrease with the increase in PO2.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 5.   Latency to CNS oxygen toxicity in the rat as a function of PCO2 and PO2 (left) and as a function of CO2 production (VCO2) and PO2 (right). The exposure PO2 in kPa is indicated next to the line by which it is represented.

For the CO2 effect, an increased level of CO2 in the inspired gas accelerates the development of CNS oxygen toxicity in humans, as well as in other mammals such as the cat, the rat, and the mouse (5). We have shown in rats that, at a constant toxic PO2, latency to CNS oxygen toxicity decreases linearly with the increase in inspired PCO2, down to a latency level from which there is no further reduction in latency with any further increase in PCO2 (5) (Fig. 5, left). At a constant toxic PO2 in the PCO2-dependent range, t = C - D × PCO2. Replacing t in the power equation will yield K<SUB>c<SUB>CO<SUB><IT>2</IT></SUB></SUB></SUB> = t2 PO<UP><SUB>2</SUB><SUP><IT>c</IT></SUP></UP> = (C - D × PCO2)2 PO<UP><SUB>2</SUB><SUP><IT>c</IT></SUP></UP>, where K<SUB>c<SUB>CO<SUB><IT>2</IT></SUB></SUB></SUB> is Kc at elevated PCO2. From this expression, the ratio of Kc at elevated PCO2 (K<SUB>c<SUB>CO<SUB><IT>2</IT></SUB></SUB></SUB>) to Kc at no CO2 (Kc0) is as follows
K<SUB>c<SUB>CO<SUB>2</SUB></SUB></SUB><IT>/K</IT><SUB><IT>c</IT><SUB>0</SUB></SUB><IT>=</IT>[(<IT>C−D×</IT>P<SC>co</SC><SUB>2</SUB>)<IT>/C</IT>]<SUP>2</SUP> (12)
Kc decreases with the increase in inspired CO2. Both C and D are a function of PO2 (5)
c=e<SUP>C<SUB>1</SUB>−D<SUB>1</SUB>×P<SC>o</SC><SUB>2</SUB></SUP> (13)
and
D=e<SUP>C<SUB>2</SUB>−D<SUB>2</SUB>×P<SC>o</SC><SUB>2</SUB></SUP> (14)
Therefore, both parameters C and D decrease with the increase in PO2. At higher PCO2 values, when latency to CNS oxygen toxicity is reduced but remains constant despite any further increase in PCO2, it was found in rats that latency to CNS oxygen toxicity t = eC3 - D3 PO2. The ratio of Kc at the maximal effect of CO2 (K<SUB>c<SUB>CO<SUB><IT>2 </IT>max</SUB></SUB></SUB>) to Kc0 is
K<SUB>c<SUB>CO<SUB>2 max</SUB></SUB></SUB><IT>/K</IT><SUB><IT>c</IT><SUB>0</SUB></SUB><IT>=</IT>(<IT>e</IT><SUP><IT>C</IT><SUB>3</SUB><IT>−D</IT><SUB>3</SUB>P<SC>o</SC><SUB>2</SUB></SUP><IT>/t</IT>)<SUP>2</SUP> (15)
where the term on the left is always positive and lower than 1.

VARIABILITY. Our laboratory has shown that there is individual sensitivity to CNS oxygen toxicity in the rat, so that the variability within the rat is much less than the variability between rats (4-7). The prediction of CNS oxygen toxicity based on individual parameters proved superior to employing the group means (7). The issue of individual sensitivity in humans has not been settled yet. Butler and Thalmann (10) suggested that there may be a small number of divers sensitive to CNS oxygen toxicity, although Harabin et al. (16) failed to prove this. However, there are no studies in humans that can be compared with the rat data, which provided clear evidence of individual sensitivity.

RECOVERY TIME CONSTANT IN HUMANS. Because measurements were not made in any other mammals, it would only be reasonable to guess that the use of body mass (BM) might provide us with an approximate solution to the problem. The rate of various physiological processes in mammals (19) is related to BM to the power -0.25. Therefore, the time for 95% recovery in humans should be 10(BMrat/BMhuman)-0.25 = 39 min, and tau human = tau rat (BMhuman/BMrat)-0.25 = 0.079 min-1, where BMrat is rat BM, BMhuman is human BM, tau human is human tau , and tau rat is rat tau . It is interesting to note that our suggestion agrees with the "rule of thumb" used by Israeli combat divers. Thus, for toxic exposures interspersed with periods of nontoxic PO2, the reduction in the value of K can be evaluated by using the suggested time constant. Although this time constant was derived from the value measured for the rat, no better approach is available at present.

CNS parameters in humans. The parameters for the power equation can be derived by using the maximum likelihood method for censored observations (APPENDIX B). We extracted those data used by Harabin et al. (17) for exposure to a constant PO2 from all of the data in Harabin's collection (Ref. 14, p. 96-136, compiled from eight different reports, mostly the work of Butler FK and Thalmann ED). The data obtained were from 661 exposures with 3.6% CNS oxygen toxicity symptoms as defined by Harabin et al. (17).

For comparison, we applied the same analysis of CNS oxygen toxicity to our rat data. To the data (n = 290) used for derivation of the power equation parameters for rats, we added exposures to low PO2 when only some rats experienced CNS oxygen toxicity. Thus for a PO2 range of 253-810 kPa, the total data included 395 exposures with 73% CNS oxygen toxicity. The parameters solved for the rat were c = 6.8 (SE = 0.2) and Kc = 6.7 ×107, P < 0.0001 chi 2 for both parameters. The power of PO2 with the data for the 395 exposures, including the low PO2 values, was higher by 1.2 than the value calculated for the data for the 290 exposures for the high PO2 values.

The parameters solved by using the model for human hyperbaric exposures were c = 15.0 (SE = 1.8) and Kc = 5.28 × 109 (P < 0.0001 chi 2 for both parameters and sigma  = 1.35). The risk for CNS oxygen toxicity was calculated by using Eq. B3 in APPENDIX B for the normal distribution
Z=[ln(<IT>t</IT>)<IT>−</IT>11.193<IT>+</IT>7.475<IT>×</IT>ln (P<SC>o</SC><SUB>2</SUB><IT>/</IT>101.3)]<IT>/</IT>1.35 (16)
The calculated risk is shown in Fig. 6 as a function of time and PO2 at 1-m depth intervals.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 6.   Percent risk of CNS oxygen toxicity as a function of time and PO2. The parameters for the calculation were derived from human hyperbaric exposures (14).

We gathered reports of 2,039 closed-circuit oxygen dives from the Israel Navy SEALS. The dives were active training fin dives in the Mediterranean Sea throughout the year at water temperatures ranging from 17 to 28°C. After each dive, the diver completed a form reporting the dive profile and marked a list of symptoms, if any. We measured 98% oxygen concentration in the inspired gas in samples taken during the dives after a few purging procedures and a VO2 of 1.4 l/min. Mean depth was 4.2 ± 0.1 (SD) m, and duration was 109 ± 54 (SD) min. Although the percentage of symptoms related to CNS oxygen toxicity in the diving data (3.5%) was similar to that found for the hyperbaric experiments, the maximum likelihood analysis did not yield significant results [chi 2 for a slope of -c/2 vs. ln(PO2) was not significant, P = 0.93]. This may be related to the low range of PO2 (132-162 kPa) for the diving data compared with the hyperbaric experiments (160-250 kPa). We, therefore, took the data from the hyperbaric exposures together with the diving data and applied the maximum likelihood method. The parameters solved using the model for the combined data were c = 6.8 (SE = 1.25) and Kc = 2.31×108 (P < 0.0001 chi 2 for both parameters and sigma  = 2.02). The calculation of the normal distribution will now be
 Z=[ln(<IT>t</IT>)<IT>−</IT>9.63<IT>+</IT>3.38<IT>×</IT>ln (P<SC>o</SC><SUB>2</SUB><IT>/</IT>101.3)]<IT>/</IT>1.35 (17)
It is interesting that the same power c (6.8) was solved for both rats and humans. This may be indicative of a similar process.

For each diving depth, we calculated the percentage of symptoms at 1-h intervals. The percentage of dives with symptoms during the first hour was added to that for the next hour, and so forth, for calculation of the cumulative risk. This cumulative percentage of CNS oxygen toxicity-related symptoms is shown in Fig. 7, represented by solid circles. We used Eq. 16 (Fig. 7, open circles) and Eq. 17 (Fig. 7, open squares) to calculate the risk. The calculated risk using the parameters derived from the hyperbaric experiments is much lower than the actual percentage of symptoms. Underestimation of the calculated risk is also evident in the calculation using parameters from both diving and hyperbaric exposures, but in this case the risk is closer to the actual data.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 7.   Percentage of symptoms related to CNS oxygen toxicity () in diving as a function of time and PO2. PO2 is shown in the top left of each panel, and the no. of dives is shown in the top right. open circle , Risk calculated from the parameters derived from hyperbaric exposures (exp); , risk calculated from the parameters derived from both hyperbaric exposures and diving.

The dives were active training dives, in which VO2 was ~1.4 l/min (8). This VO2 is higher than that in the hyperbaric experiments, in which 6 min of exercise (1.3 l O2/min) were followed by 4 min of rest (17). This protocol would yield a mean VO2 of 0.9 l/min. The weighted mean VO2 for both diving and experimental data is 1.28 l O2/min. It is possible that the three lines in each of the panels in Fig. 7 represent the risk at three separate levels of VO2.

We used our model with the parameters derived from the hyperbaric experiments and from diving and hyperbaric experiments taken together to calculate the risk within the suggested limits of the United States Navy Single PO2 Diving Limits (21) (Fig. 8, Table 1). This calculated risk is higher than the calculated risk of Harabin et al. (17), mainly at 25 and 30 ft. When we calculated the time at which 5 or 10% of the divers will experience symptoms related to CNS oxygen toxicity (using both the parameters from the hyperbaric experiments and those obtained from diving + hyperbaric experiments), the time was less than the suggested limits for 25 and 30 ft.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 8.   Percent risk of CNS oxygen toxicity as a function of time and PO2. The parameters for the calculation were derived from both hyperbaric experiments and diving.


                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Calculation of the risk of CNS oxygen toxicity within the limits suggested by the US Navy

Two versions of the power equation describing CNS oxygen toxicity in humans were 5.28 × 109 = t2 (PO2/101.3)15.0 for an VO2 of 0.9 l/min and 2.31 × 108 = t2(PO2/101.3)6.8 for an VO2 of 1.28 l/min. It is too soon to use these two sets of data to derive the complete effect of metabolic rate in humans (Eqs. 9-11), and there are no data available that can be used to derive the effect of CO2 on CNS oxygen toxicity (Eqs. 12-15). Further studies using larger mammals may help in the derivation of these expressions using an allometric approach. Calculated limits were determined for the symptoms suggested by Harabin et al. (17): nausea, numbness, dizziness, twitching, hearing and visual disturbances, unconsciousness, and convulsion. However, if some of the milder symptoms, such as dizziness and nausea, are not taken into consideration, the parameters of the power equation will be different. Evidently, the data for humans are far from complete. Some of the reported symptoms may not be related to CNS oxygen toxicity, and the data for real diving were obtained only for the low range of toxic PO2.

In conclusion, the power equation is a simplified expression derived from the principles of the ROS kinetics. The power equation for cumulative oxygen toxicity and the exponential recovery successfully describe various phenomena of oxygen toxicity. We suggest the use of these expressions to calculate the risk of pulmonary and CNS oxygen toxicity in humans and the rate of recovery.


    APPENDIX A
TOP
ABSTRACT
INTRODUCTION
QUANTITATIVE EXPRESSIONS FOR...
SELECTING THE PARAMETERS FOR...
APPENDIX A
APPENDIX B
REFERENCES

Calculation of Cumulative Oxygen Toxicity When PO2 Is Not Constant

Using Eq. 1, let us assume in step 1 exposure for a time t1 to a partial pressure of oxygen PO2 1. Then
DMG<SUB>1</SUB><IT>=a×t</IT><SUP>2</SUP><SUB>1</SUB>P<SC>o</SC><SUP><IT>c</IT></SUP><SUB>2 1</SUB>
Let us define t'1 as the time that will produce the same damage as DMG1 but at a second PO2, namely PO2 2. Then
DMG<SUB>1</SUB><IT>=a×t</IT><SUP>2</SUP><SUB>1</SUB>P<SC>o</SC><SUP><IT>c</IT></SUP><SUB>2 1</SUB><IT>=a×t′</IT><SUB>1</SUB><SUP>2</SUP>P<SC>o</SC><SUP><IT>c</IT></SUP><SUB>2 2</SUB>
from which it follows that
t′<SUB>1</SUB>=t<SUB>1</SUB>(P<SC>o</SC><SUB>2 1</SUB><IT>/</IT>P<SC>o</SC><SUB>2 2</SUB>)<SUP><IT>c/</IT>2</SUP> (A1)
The damage after a second time interval t2 will be
DMG<SUB>2</SUB><IT>=a</IT>(<IT>t′</IT><SUB>1</SUB><IT>+t</IT><SUB>2</SUB>)<SUP>2</SUP>P<SC>o</SC><SUP><IT>c</IT></SUP><SUB>2 2</SUB><IT>=a</IT>[(<IT>t′</IT><SUB>1</SUB><IT>+t</IT><SUB>2</SUB>)P<SC>o</SC><SUP><IT>c/</IT>2</SUP><SUB>2 2</SUB>]<SUP>2</SUP>
Replacing t'1 by its value in Eq. A1, we obtain
DMG<SUB>2</SUB><IT>=a</IT>{[<IT>t</IT><SUB>1</SUB>(P<SC>o</SC><SUB>2 1</SUB><IT>/</IT>P<SC>o</SC><SUB>2 2</SUB>)<SUP><IT>c/</IT>2</SUP><IT>+t</IT><SUB>2</SUB>]P<SC>o</SC><SUP><IT>c/</IT>2</SUP><SUB>2 2</SUB>}<SUP>2</SUP><IT>=a</IT>[<IT>t</IT><SUB>1</SUB>P<SC>o</SC><SUP><IT>c/</IT>2</SUP><SUB>2 1</SUB><IT>+t</IT><SUB>2</SUB>P<SC>o</SC><SUP><IT>c/</IT>2</SUP><SUB>2 2</SUB>]<SUP>2</SUP>
The time t2T at PO2 2 that will yield DMG2 is
t<SUB>2T</SUB><IT>=</IT><IT>t′</IT><SUB>1</SUB><IT>+t</IT><SUB>2</SUB><IT>=t</IT><SUB>1</SUB>(P<SC>o</SC><SUB>2 1</SUB><IT>/</IT>P<SC>o</SC><SUB>2 2</SUB>)<SUP><IT>c/</IT>2</SUP><IT>+t</IT><SUB>2</SUB>

=t<SUB>1</SUB>(P<SC>o</SC><SUB>2 1</SUB><IT>/</IT>P<SC>o</SC><SUB>2 2</SUB>)<SUP><IT>c/</IT>2</SUP><IT>+t</IT><SUB>2</SUB>(P<SC>o</SC><SUB>2 2</SUB><IT>/</IT>P<SC>o</SC><SUB>2 2</SUB>)<SUP><IT>c/</IT>2</SUP>
The expressions
DMG<SUB><IT>n</IT></SUB><IT>=a </IT><FENCE><LIM><OP>∑</OP><LL><IT>i=</IT>1</LL><UL><IT>n</IT></UL></LIM><IT> t<SUB>i</SUB></IT>P<SC>o</SC><SUP><IT>c/</IT>2</SUP><SUB>2<IT> i</IT></SUB></FENCE><SUP>2</SUP>
and
t<SUB>nT</SUB><IT>=</IT><LIM><OP>∑</OP><LL><IT>i=</IT>1</LL><UL><IT>n</IT></UL></LIM><IT> t<SUB>i</SUB></IT>(P<SC>o</SC><SUB>2<IT> i</IT></SUB><IT>/</IT>P<SC>o</SC><SUB>2<IT> n</IT></SUB>)<SUP><IT>c/</IT>2</SUP>
hold for n = 2. Let us assume that this is true for n steps and prove that it is true for n + 1.

Let us define t'n as the time at POn+1 that will produce DMGn. Then
DMG<SUB><IT>n</IT></SUB><IT>=at</IT><SUP>2</SUP><SUB><IT>n</IT>T</SUB>P<SC>o</SC><SUP><IT>c</IT></SUP><SUB>2<IT> n</IT></SUB><IT>=at′<SUB>n</SUB></IT><SUP>2</SUP>P<SC>o</SC><SUP><IT>c</IT></SUP><SUB>2<IT> n+</IT>1</SUB>
from which it follows that
t′<SUB>n</SUB>=t<SUB>nT</SUB>(P<SC>o</SC><SUB>2<IT> n</IT></SUB><IT>/</IT>P<SC>o</SC><SUB>2<IT> n+</IT>1</SUB>)<SUP><IT>c/</IT>2</SUP>
and
t<SUB>(n+1)T</SUB><IT>=t′<SUB>n</SUB>+t</IT><SUB><IT>n+</IT>1</SUB><IT>=</IT><FENCE><LIM><OP>∑</OP><LL><IT>i=</IT>1</LL><UL><IT>n</IT></UL></LIM><IT> t<SUB>i</SUB></IT>(P<SC>o</SC><SUB>2<IT> i</IT></SUB><IT>/</IT>P<SC>o</SC><SUB>2<IT> n</IT></SUB>)<SUP><IT>c/</IT>2</SUP></FENCE>(P<SC>o</SC><SUB>2<IT> n</IT></SUB><IT>/</IT>P<SC>o</SC><SUB>2<IT> n+</IT>1</SUB>)<SUP><IT>c/</IT>2</SUP><IT>+t</IT><SUB><IT>n+</IT>1</SUB><IT>=</IT><FENCE><LIM><OP>∑</OP><LL><IT>i=</IT>1</LL><UL><IT>n</IT></UL></LIM><IT> t<SUB>i</SUB></IT>(P<SC>o</SC><SUB>2<IT> i</IT></SUB><IT>/</IT>P<SC>o</SC><SUB>2<IT> n+</IT>1</SUB>)<SUP><IT>c/</IT>2</SUP></FENCE><IT>+t</IT><SUB><IT>n+</IT>1</SUB><IT>=</IT><LIM><OP>∑</OP><LL><IT>i=</IT>1</LL><UL><IT>n</IT></UL></LIM><IT> t<SUB>i</SUB></IT>(P<SC>o</SC><SUB>2<IT> i</IT></SUB><IT>/</IT>P<SC>o</SC><SUB>2<IT> n+</IT>1</SUB>)<SUP><IT>c/</IT>2</SUP><IT>+t</IT><SUB><IT>n+</IT>1</SUB>(P<SC>o</SC><SUB>2<IT> n+</IT>1</SUB><IT>/</IT>P<SC>o</SC><SUB>2<IT> n+</IT>1</SUB>)<SUP><IT>c/</IT>2</SUP><IT>=</IT><LIM><OP>∑</OP><LL><IT>i=</IT>1</LL><UL><IT>n+</IT>1</UL></LIM><IT> t<SUB>i</SUB></IT>(P<SC>o</SC><SUB>2<IT> i</IT></SUB><IT>/</IT>P<SC>o</SC><SUB>2<IT> n+</IT>1</SUB>)<SUP><IT>c/</IT>2</SUP>
Thus
DMG<SUB><IT>n+</IT>1</SUB><IT>=at</IT><SUP>2</SUP><SUB>(<IT>n+</IT>1)T</SUB>P<SC>o</SC><SUP><IT>c</IT></SUP><SUB>2<IT> n+</IT>1</SUB><IT>=a</IT><FENCE><LIM><OP>∑</OP><LL><IT>i=</IT>1</LL><UL><IT>n+</IT>1</UL></LIM><IT> t<SUB>i</SUB></IT>(P<SC>o</SC><SUB>2<IT> i</IT></SUB><IT>/</IT>P<SC>o</SC><SUB>2<IT> n+</IT>1</SUB>)<SUP><IT>c/</IT>2</SUP></FENCE><SUP>2</SUP>P<SC>o</SC><SUP><IT>c</IT></SUP><SUB>2<IT> n+</IT>1</SUB><IT>=a</IT><FENCE><FENCE><LIM><OP>∑</OP><LL><IT>i=</IT>1</LL><UL><IT>n+</IT>1</UL></LIM><IT> t<SUB>i</SUB></IT>(P<SC>o</SC><SUB>2<IT> i</IT></SUB><IT>/</IT>P<SC>o</SC><SUB>2<IT> n+</IT>1</SUB>)<SUP><IT>c/</IT>2</SUP></FENCE>P<SC>o</SC><SUP><IT>c/</IT>2</SUP><SUB>2<IT> n+</IT>1</SUB></FENCE><SUP>2</SUP><IT>=a </IT><FENCE><LIM><OP>∑</OP><LL><IT>i=</IT>1</LL><UL><IT>n+</IT>1</UL></LIM><IT> t<SUB>i</SUB></IT>P<SC>o</SC><SUP><IT>c/</IT>2</SUP><SUB>2<IT> i</IT></SUB></FENCE><SUP>2</SUP> (A2)
For PO2 as a continuous function of t, Eq. A2 yields
DMG<SUB><IT>t</IT></SUB><IT>=a </IT><FENCE><LIM><OP>∫</OP><LL>0</LL><UL><IT>t</IT><SUB>ox</SUB></UL></LIM> P<SC>o</SC><SUP><IT>c/</IT>2</SUP><SUB>2</SUB>d<IT>t</IT></FENCE><SUP>2</SUP> (A3)
For all-or-none effects, DMG should be replaced by K, and the parameter a should be omitted, giving
K=<FENCE><LIM><OP>∑</OP><LL>i=1</LL><UL>n+1</UL></LIM> t<SUB>i</SUB>P<SC>o</SC><SUP><IT>c/</IT>2</SUP><SUB>2<IT> i</IT></SUB></FENCE><SUP>2</SUP> (A4)
or
K=<FENCE><LIM><OP>∫</OP><LL>0</LL><UL>t<SUB>ox</SUB></UL></LIM> P<SC>o</SC><SUP><IT>c/</IT>2</SUP><SUB>2</SUB>d<IT>t</IT></FENCE><SUP>2</SUP> (A5)


    APPENDIX B
TOP
ABSTRACT
INTRODUCTION
QUANTITATIVE EXPRESSIONS FOR...
SELECTING THE PARAMETERS FOR...
APPENDIX A
APPENDIX B
REFERENCES

Solution of the Parameters of the Power Equation

The power equation describes the increasing risk of CNS oxygen toxicity as K approaches
K<SUB>c</SUB>: K=t<SUP>2</SUP>P<SC>o</SC><SUP><IT>c</IT></SUP><SUB>2</SUB> (B1)
From the available data, in the ith individual exposed to PO2 i, CNS oxygen toxicity occurs at time ti. There are individuals in whom toxicity does not occur, so that ti may be censored. Formally, the observations are given in the following forms
(y<SUB>i</SUB>, &dgr;<SUB>i</SUB>, P<SC>o</SC><SUB>2<IT>i</IT></SUB>)<IT>,  i=</IT>1,<IT>…, n,</IT> (B2)
where yi = min(ti, ci), delta i = I(tiless or equal ci), and ci are the censor variables, and delta i is the indicator showing whether the observation is censored or not. The goal is to fit the censored data (Eq. B2) to the model (Eq. B1).

Considering t as the response variable, one can write
ln<IT> t<SUB>i</SUB>=</IT>½ln(<IT>K<SUB>c</SUB></IT>)<IT>+</IT>½<IT>c×</IT>ln(P<SC>o</SC><SUB>2</SUB>)
Thus c and K can be estimated by using parametric regression techniques for the survival data. The idea is that
Z<SUB>i</SUB>=<FR><NU>ln(<IT>t<SUB>i</SUB></IT>)<IT>−</IT>(<IT>c/</IT>2)ln(P<SC>o</SC><SUB>2<IT>i</IT></SUB>)<IT>−</IT>(½)ln(<IT>K<SUB>c</SUB></IT>)</NU><DE><IT>&sfgr;</IT></DE></FR>
has some distribution f, where ln ti can be censored. The likelihood function is written as follows
1(c, K<SUB>c</SUB>, &sfgr;)=<FENCE><LIM><OP>∏</OP><LL>i:uncensored</LL></LIM><IT> f</IT>(<IT>Z<SUB>i</SUB></IT>)</FENCE><FENCE><LIM><OP>∏</OP><LL><IT>i:</IT>censored</LL></LIM> <LIM><OP>∫</OP><LL><IT>Z<SUB>i</SUB></IT></LL><UL><IT>∞</IT></UL></LIM><IT> f</IT>(<IT>x</IT>)d<IT>x</IT></FENCE>
Then l(c, Kc, sigma ) or ln l(c, Kc, sigma ) is minimized over c, Kc, and sigma  numerically. Distributions for Zi can be chosen from the following list: 1) Gausian, Zi ~ N(0,1); 2) smallest extreme value, if t has the smallest extreme value distribution, then et has a Weibull distribution; and 3) logistic, yields a closed form expression.

In our computations, we used the smallest extreme value distribution. The results obtained are not so sensitive to the choice of f from the above list.

The risk can then be calculated from the normal distribution
Z=[ln(<IT>t</IT>)<IT>−&mgr;</IT>]<IT>/&sfgr;</IT> (B3)

&mgr;=E[ln(<IT>t</IT>)]<IT>=</IT>0.5 ln(<IT>K<SUB>c</SUB></IT>)<IT>+</IT>(<IT>c/</IT>2)ln(P<SC>o</SC><SUB>2</SUB>)
where t is in minutes, and PO2 is in kPa.


    ACKNOWLEDGEMENTS

The authors thank R. Lincoln for skillful editing and Y. Roth for assistance with the mathematical formulation in APPENDIX A.


    FOOTNOTES

The opinions and assertions contained herein are the private ones of the authors and are not to be construed as official or as reflecting the views of the Israel Naval Medical Institute.

Address for reprint requests and other correspondence: R. Arieli, Israel Naval Medical Institute, POB 8040, Haifa 31080, Israel (E-mail: rarieli{at}netvision.net.il).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 4 May 2001; accepted in final form 21 September 2001.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
QUANTITATIVE EXPRESSIONS FOR...
SELECTING THE PARAMETERS FOR...
APPENDIX A
APPENDIX B
REFERENCES

1.   Arieli, R. Power expression for O2 toxicity as a function of time and pressure. In: Proceedings of the XVth Meeting of the European Undersea Biomedical Society (EUBS), , edited by Bitterman N, and Lincoln R.. Tel Aviv, Israel: Israeli Navy Publications, 1989, p. 108-114.

2.   Arieli, R. Oxygen toxicity as a function of time and PO2. J Basic Clin Physiol Pharmacol 5: 67-87, 1994[Medline].

3.   Arieli, R. Power equation for all-or-none effects of oxygen toxicity and cumulative oxygen toxicity. J Basic Clin Physiol Pharmacol 5: 207-225, 1994[Medline].

4.   Arieli, R. Latency of oxygen toxicity of the central nervous system in rats as a function of carbon dioxide production and partial pressure of oxygen. Eur J Appl Physiol 78: 454-459, 1998.

5.   Arieli, R, and Ertracht O. Latency to CNS oxygen toxicity in rats as a function of PCO2 and PO2. Eur J Appl Physiol 80: 598-603, 1999.

6.   Arieli, R, and Gutterman A. Recovery time constant in central nervous system O2 toxicity in the rat. Eur J Appl Physiol 75: 182-187, 1997.

7.   Arieli, R, and Hershko G. Prediction of central nervous system oxygen toxicity in rats. J Appl Physiol 77: 1903-1906, 1994[Abstract/Free Full Text].

8.   Arieli, R, Kerem D, Gonen A, Goldenberg I, Shoshani O, Daskalovic YI, and Shupak A. Thermal status of wet-suited divers using closed circuit O2 apparatus in sea water of 17-18.5°C. Eur J Appl Physiol 76: 69-74, 1997.

9.   Bardin, H, and Lambertsen CJ. A Quantitative Method for Calculating Pulmonary Toxicity. Use of the "Unit Pulmonary Toxicity Dose" (UPTD). Institute for Environmental Medicine Report. Philadelphia, PA: University of Pennsylvania, 1970.

10.   Butler, FK, Jr, and Thalmann ED. Central nervous system oxygen toxicity in closed circuit scuba divers II. Undersea Biomed Res 13: 193-223, 1986[Web of Science][Medline].

11.   Clark, JM, Jackson RM, Lambertsen CJ, Gelfand R, Hiller WDB, and Unger M. Pulmonary function in men after oxygen breathing at 3.0 ATA for 35 h. J Appl Physiol 71: 878-885, 1991[Abstract/Free Full Text].

12.   Clark, JM, Lambertsen CJ, Gelfand R, Flores ND, Pisarello JB, Rossman MD, and Elias JA. Effects of prolonged oxygen exposure at 1.5, 20, or 25 ATA on pulmonary function in men (Predictive Studies V). J Appl Physiol 86: 243-259, 1999[Abstract/Free Full Text].

13.   Eckenhoff, RG, Dougherty JH, Jr, Messier AA, Osborne SF, and Parker JW. Progression of and recovery from pulmonary oxygen toxicity in humans exposed to 5 ATA air. Aviat Space Environ Med 58: 658-667, 1987[Medline].

14.   Harabin, AL. Human Central Nervous System Oxygen Toxicity Data from 1945 to 1986. Bethesda, MD: Naval Medical Research Institute, 1993. (NMRI Report 93-03)

15.   Harabin, AL, Homer LD, Weathersby PK, and Flynn ET. An analysis of decrements in vital capacity as an index of pulmonary oxygen toxicity. J Appl Physiol 63: 1130-1135, 1987[Abstract/Free Full Text].

16.   Harabin, AL, Survanshi SS, and Homer LD. A test for variations in individual sensitivity to hyperbaric oxygen toxicity. Undersea Hyperb Med 21: 403-412, 1994[Medline].

17.   Harabin, AL, Survanshi SS, and Homer LD. A model for predicting central nervous system oxygen toxicity from hyperbaric oxygen exposures in humans. Toxicol Appl Pharmacol 132: 19-26, 1995[Medline].

18.   Harabin, AL, Survanshi SS, Weathersby PK, Hays JR, and Homer LD. The modulation of oxygen toxicity by intermittent exposure. Toxicol Appl Pharmacol 93: 298-311, 1988[Medline].

19.   Stahl, WR. Scaling of respiratory variables in mammals. J Appl Physiol 22: 453-460, 1967[Free Full Text].

20.   US Department of the Navy. U.S. Navy Diving Manual. Washington, DC: Dept. of the Navy, 1978, vol. 1, chapt. 8. (NAVSEA 0094-LP-001-9010)

21.   US Department of the Navy. Closed-circuit oxygen UBA. In: U. S. Navy Diving Manual. Washington, DC: Naval Sea Systems Command, 1991, vol. 2, p. 14-6. (NAVSEA 0994-lp-001-9120)

22.   Waisman, D, Arieli R, Kerem D, and Melamed Y. Recovery of the hypoxic ventilatory drive of rats from the toxic effect of hyperbaric oxygen. Aviat Space Environ Med 63: 280-286, 1992[Medline].


J APPL PHYSIOL 92(1):248-256
8750-7587/02 $5.00 Copyright © 2002 the American Physiological Society



This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
R. Arieli, O. Ertracht, I. Oster, A. Vitenstein, and Y. Adir
Effects of nitrogen and helium on CNS oxygen toxicity in the rat
J Appl Physiol, January 1, 2005; 98(1): 144 - 150.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arieli, R.
Right arrow Articles by Goldenshluger, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arieli, R.
Right arrow Articles by Goldenshluger, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online